While talking about Glucose Monitoring System, the first coming up will be traditional Blood Glucose Monitoring (BGM). However, there is a human desire to be connected. Bionime will exposure the very first MIT Continuous Glucose Monitoring (CGM) system on EASD 2022.
Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment of diabetes eco-system for 20 years. Bionime builds its own brand, Rightest, which aimed at improving the lives of people with well-lifestyle in diabetes patients, the CGM system provides 24-hour real-time glucose tracking and data transmission.
The Brand new “RIGHTEST iFree CGM” will be the first step stone for our mission! Based on industry 4.0 specifications, the RIGHTEST iFree CGM promises ease-to-use, as well as a mobile app available for any Bluetooth devices to record glucose and to communicate with relatives. Via the Internet cloud, hospital systems and doctor are allowing triage & continuous two-way interactions. “This, iFree CGM, we promise will let can affordable for whose needs the CGM targets”, says Roy Huang, CEO of Bionime.
Want to know the upcoming information of Rightest iFree CGM!
Join us at EASD in Stockholm 2022. Meet Bionime booth for more hot news and feature of Rightest iFree CGM.
B hall Booth: F.02
Date: 20th Sep-22nd Sep
Venue: Stockholmsmässan, Stockholm, Sweden
iFree, Free your life!